CDC announces major changes to U.S. childhood vaccine schedule, cutting the number of shots recommended for American children ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Moderna Inc. (NASDAQ: MRNA) is advancing its vaccine portfolio, with regulatory submissions underway for its seasonal ...

An update from Moderna ( ($MRNA) ) is now available. In a January 5, 2026 letter to shareholders, Moderna reviewed a challenging 2025 operating ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...

A research team has developed an AI-based personalized cancer vaccine design technology that enables long-term immunity that ...

Researchers found that in mouse models (in a lab), SARS‑CoV‑2 mRNA vaccination triggered strong type I interferon signals, ...

Influenza has caused 3,100 deaths and 81,000 hospitalizations among 7.5 million flu cases so far this respiratory disease ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

The total number of lives saved since the first vaccines is mindboggling, well over a billion globally and perhaps two ...